163 related articles for article (PubMed ID: 36731243)
21. Prognostic value of sarcopenia in patients treated by Radiochemotherapy for locally advanced oesophageal cancer.
Mallet R; Modzelewski R; Lequesne J; Mihailescu S; Decazes P; Auvray H; Benyoucef A; Di Fiore F; Vera P; Dubray B; Thureau S
Radiat Oncol; 2020 May; 15(1):116. PubMed ID: 32443967
[TBL] [Abstract][Full Text] [Related]
22. Sarcopenia Was a Poor Prognostic Predictor for Patients With Advanced Lung Cancer Treated With Immune Checkpoint Inhibitors.
Li S; Liu Z; Ren Y; Liu J; Lv S; He P; Yang Y; Sun Y; Chang J; Luo D; Cong M
Front Nutr; 2022; 9():900823. PubMed ID: 35923193
[TBL] [Abstract][Full Text] [Related]
23. Skeletal muscle loss is an independent negative prognostic factor in patients with advanced lower rectal cancer treated with neoadjuvant chemoradiotherapy.
Takeda Y; Akiyoshi T; Matsueda K; Fukuoka H; Ogura A; Miki H; Hiyoshi Y; Nagasaki T; Konishi T; Fujimoto Y; Fukunaga Y; Ueno M
PLoS One; 2018; 13(4):e0195406. PubMed ID: 29630652
[TBL] [Abstract][Full Text] [Related]
24. Muscle loss during primary debulking surgery and chemotherapy predicts poor survival in advanced-stage ovarian cancer.
Huang CY; Yang YC; Chen TC; Chen JR; Chen YJ; Wu MH; Jan YT; Chang CL; Lee J
J Cachexia Sarcopenia Muscle; 2020 Apr; 11(2):534-546. PubMed ID: 31999069
[TBL] [Abstract][Full Text] [Related]
25. Outcomes and prognostic factors in patients with locally advanced cervical cancer treated with concurrent chemoradiotherapy.
Liu J; Tang G; Zhou Q; Kuang W
Radiat Oncol; 2022 Aug; 17(1):142. PubMed ID: 35978412
[TBL] [Abstract][Full Text] [Related]
26. Impact of low skeletal muscle mass and quality on clinical outcomes in patients with head and neck cancer undergoing (chemo)radiation.
Bardoscia L; Besutti G; Pellegrini M; Pagano M; Bonelli C; Bonelli E; Braglia L; Cozzi S; Roncali M; Iotti C; Pinto C; Pattacini P; Ciammella P
Front Nutr; 2022; 9():994499. PubMed ID: 36466387
[TBL] [Abstract][Full Text] [Related]
27. Associations of muscle and adipose tissue parameters with long-term outcomes in middle and low rectal cancer: a retrospective cohort study.
Liu J; Yu X; Huang X; Lai Q; Chen J
Cancer Imaging; 2023 Jan; 23(1):5. PubMed ID: 36635737
[TBL] [Abstract][Full Text] [Related]
28. Prognostic role of computed tomography-based, artificial intelligence-driven waist skeletal muscle volume in uterine endometrial carcinoma.
Kim SI; Chung JY; Paik H; Seol A; Yoon SH; Kim TM; Kim HS; Chung HH; Cho JY; Kim JW; Lee M
Insights Imaging; 2021 Dec; 12(1):192. PubMed ID: 34928453
[TBL] [Abstract][Full Text] [Related]
29. [Outcomes and prognostic factors of advanced squamous cervical cancer after concurrent chemoradiotherapy].
Binbin T; Lingying W; Manni H; Jusheng A; Ning L
Zhonghua Fu Chan Ke Za Zhi; 2014 May; 49(5):348-54. PubMed ID: 25030731
[TBL] [Abstract][Full Text] [Related]
30. Prognostic value of sarcopenia in adults with solid tumours: A meta-analysis and systematic review.
Shachar SS; Williams GR; Muss HB; Nishijima TF
Eur J Cancer; 2016 Apr; 57():58-67. PubMed ID: 26882087
[TBL] [Abstract][Full Text] [Related]
31. Predicting the Overall Survival in Patients with Advanced Pancreatic Cancer by Calculating L3 Skeletal Muscle Index Derived from CT.
Özkul B; Özkul Ö; Bilir C
Curr Med Imaging; 2022; 18(10):1079-1085. PubMed ID: 35240961
[TBL] [Abstract][Full Text] [Related]
32. Impact of Low Skeletal Muscle Mass on the Prognosis of Patients with Head and Neck Cancer Treated Nonsurgically.
Iwasa YI; Kitoh R; Hiramatsu K; Sugiyama K; Watanabe K; Yasukawa R; Shinagawa J; Miyajima H; Yokota Y; Kobayashi M; Kitano T; Mori K; Takumi Y
ORL J Otorhinolaryngol Relat Spec; 2023; 85(1):36-43. PubMed ID: 36423591
[TBL] [Abstract][Full Text] [Related]
33. Skeletal muscle index impacts the treatment outcome of elderly patients with diffuse large B cell lymphoma.
Niiyama-Uchibori Y; Okamoto H; Miyashita A; Mizuhara K; Kanayama-Kawaji Y; Fujino T; Tsukamoto T; Mizutani S; Shimura Y; Teramukai S; Kuroda J
Hematol Oncol; 2024 Jan; 42(1):e3252. PubMed ID: 38287527
[TBL] [Abstract][Full Text] [Related]
34. Influence of skeletal muscle and intermuscular fat on postoperative complications and long-term survival in rectal cancer patients.
Nie T; Wu F; Heng Y; Cai W; Liu Z; Qin L; Cao Y; Zheng C
J Cachexia Sarcopenia Muscle; 2024 Apr; 15(2):702-717. PubMed ID: 38293722
[TBL] [Abstract][Full Text] [Related]
35. Skeletal Muscle Mass Reduction Velocity as a Simple Prognostic Indicator for Patients with Metastatic Urothelial Carcinoma Receiving Second-Line Chemotherapy.
Nagai T; Naiki T; Iida K; Nozaki S; Etani T; Sugiyama Y; Ando R; Yanase T; Chaya R; Moritoki Y; Kobayashi D; Akita H; Okamura T; Yasui T
Asian Pac J Cancer Prev; 2019 Oct; 20(10):2995-3000. PubMed ID: 31653146
[TBL] [Abstract][Full Text] [Related]
36. Loss of skeletal muscle index and survival in patients with metastatic colorectal cancer: Secondary analysis of the phase 3 CAIRO3 trial.
Kurk SA; Peeters PHM; Dorresteijn B; de Jong PA; Jourdan M; Creemers GM; Erdkamp FLG; de Jongh FE; Kint PAM; Poppema BJ; Radema SA; Simkens LHJ; Tanis BC; Tjin-A-Ton MLR; Van Der Velden A; Punt CJA; Koopman M; May AM
Cancer Med; 2020 Feb; 9(3):1033-1043. PubMed ID: 31850687
[TBL] [Abstract][Full Text] [Related]
37. Predictive impact of sarcopenia in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors: A retrospective study.
Feng Y; Wang L; Guo F; Zhu F; Shi J; Wang Y; Zhang Y; Chen X; Zhang L
Heliyon; 2024 Mar; 10(5):e27282. PubMed ID: 38463845
[TBL] [Abstract][Full Text] [Related]
38. Impact of skeletal muscle mass in patients with unresectable gastric cancer who received palliative first-line chemotherapy based on 5-fluorouracil.
Matsunaga T; Saito H; Miyauchi W; Shishido Y; Miyatani K; Morimoto M; Murakami Y; Hanaki T; Kihara K; Yamamoto M; Tokuyasu N; Takano S; Sakamoto T; Hasegawa T; Fujiwara Y
BMC Cancer; 2021 Nov; 21(1):1219. PubMed ID: 34774016
[TBL] [Abstract][Full Text] [Related]
39. CT-measured skeletal muscle mass used to assess frailty in patients with head and neck cancer.
Zwart AT; van der Hoorn A; van Ooijen PMA; Steenbakkers RJHM; de Bock GH; Halmos GB
J Cachexia Sarcopenia Muscle; 2019 Oct; 10(5):1060-1069. PubMed ID: 31134765
[TBL] [Abstract][Full Text] [Related]
40. Muscle radiodensity loss during cancer therapy is predictive for poor survival in advanced endometrial cancer.
Lee J; Lin JB; Wu MH; Jan YT; Chang CL; Huang CY; Sun FJ; Chen YJ
J Cachexia Sarcopenia Muscle; 2019 Aug; 10(4):814-826. PubMed ID: 31094101
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
